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hlgBC) was reduced, whereas that of host defence evasion 
components (cap, sspAB, katA) was increased. In particular, 
members of the SaeRS regulon had highly reduced expres-
sion, and the use of specific mutants revealed that the effect 
on toxin production is likely mediated via SaeRS.
Keywords S. aureus · Skin fatty acid · C-6-H · 
Resistance
Introduction
The Gram-positive bacterium Staphylococcus aureus is able 
to survive as a commensal organism in the anterior nares and 
on human skin. A third of the human population are nasal 
carriers and two-thirds are intermittent carriers, forming a 
Abstract Staphylococcus aureus is a commensal of the 
human nose and skin. Human skin fatty acids, in particular 
cis-6-hexadecenoic acid (C-6-H), have high antistaphylococ-
cal activity and can inhibit virulence determinant production. 
Here, we show that sub-MIC levels of C-6-H result in induc-
tion of increased resistance. The mechanism(s) of C-6-H 
activity was investigated by combined transcriptome and 
proteome analyses. Proteome analysis demonstrated a pleio-
tropic effect of C-6-H on virulence determinant production. 
In response to C-6-H, transcriptomics revealed altered expres-
sion of over 500 genes, involved in many aspects of virulence 
and cellular physiology. The expression of toxins (hla, hlb, 
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large reservoir for potential infection (Peacock et al. 2001). 
As a pathogen, S. aureus is highly adaptable, with an alarm-
ing spread of antibiotic resistance. This limits the range of 
effective therapies able to combat this organism. S. aureus is 
able to cause a wide range of diseases, from minor skin infec-
tions to severe systemic disease (such as bacteraemia, septic 
arthritis and endocarditis). Also, in the hospital environment, 
S. aureus is responsible for many infections associated with 
surgical wounds and catheters. The ability to inhabit so many 
niches with such a range of infectious sequelae is due to a 
large repertoire of virulence determinants.
The human body has many innate defence mechanisms 
to prevent infection by invading microbes. Physical barriers 
(human skin and mucosa) prevent pathogens from ingress. 
The human skin is composed of tightly bound epithelial cells 
and covered by a highly cross-linked layer of keratin and is 
therefore normally impenetrable to bacteria (Proksch et al. 
2008). Additionally, the skin produces antimicrobial peptides 
as well as skin fatty acids which are crucial for host defence 
(Ong et al. 2002; Niyousaba and Ogawa 2005). Several fatty 
acids have been isolated from human skin, which have strong 
antimicrobial activity (Miller et al. 1988; Wille and Kydonieus 
2003). The antibacterial activity of unsaturated fatty acids has 
been well known for many years (Kabara et al. 1972; Knapp 
and Melly 1986; Shin et al. 2007), the most effective antistaph-
ylococcal skin fatty acid being cis-6-hexadecanoic acid (C-6-
H, sapienic acid, C16:1Δ6) (Takigawa et al. 2005; Wille and 
Kydonieus 2003). As well as being antibacterial, C-6-H also 
has the ability to inhibit virulence determinant production and 
the induction of antibiotic resistance mechanisms (Clarke et 
al. 2007; Projan et al. 1994; Schlievert et al. 1992; Takigawa 
et al. 2005; Kenny et al. 2009). In fact, in murine models of 
S. aureus infection, C-6-H has shown to be an effective treat-
ment. Thus, it is important to understand how C-6-H mediates 
its effects and the response of S. aureus to such assault. A sur-
face protein, IsdA, has been shown to be involved in resistance 
of S. aureus to C-6-H by rendering the cells more hydrophilic 
(Clarke et al. 2007). Also, wall teichoic acids are required to 
prevent susceptibility to C-6-H (Kohler et al. 2009).
In order to define bacterial components important 
in resistance to C-6-H and how its effect on virulence 
determinant expression is mediated, a global study of 
gene expression and protein profile analysis in response to 
C-6-H was carried out.
Materials and methods
Bacterial strains and culture conditions
Bacterial strains used in this study are listed in Table 1 
and were grown in iron-limited tryptic soy broth (TSB−Fe) 
(Oxoid), Chelex-100 (Sigma Aldrich), with the addition of 
20 µM 2,2′-dipyridyl (Baldassarri et al. 2001). Antibiotics 
used were erythromycin (5 µg/ml), lincomycin (25 µg/ml) 
or tetracycline (5 µg/ml) where appropriate. Cultures were 
grown at 37 °C and inoculated with an overnight culture to 
an optical density at 600 nm (OD600) of 0.05 into TSB−Fe, 
followed by incubation with agitation at 37 °C. Bacterial 
growth was monitored by measuring the OD600.
Bacterial killing assays
Bacteria were grown to an OD600 of approximately 0.6 in 
TSB−Fe. Cells from 10 ml of culture were harvested by 
centrifugation for 10 min at 5,000×g and 4 °C. The cell 
pellet was washed twice in sterile dH2O by resuspension 
and centrifugation as above. OD600 was measured, and 
cell suspension was adjusted to OD600 of 1.0. Cells were 
incubated at 37 °C with cis-6-hexadecanoic acid (C-6-H; 
Matreya) and cfu determined at intervals by plating onto 
TSB−Fe agar. For C-6-H pre-exposure experiments, bacte-
ria were grown to an OD600 of 0.5 in TSB−Fe and 8 µg/ml 
C-6-H was added, prior to continued incubation, with shak-
ing, for 2 h by 37 °C. Cells were then harvested, washed 
and exposed to C-6-H in the killing assay, as above.
Transcriptional analysis
Total RNA was isolated from cultures (OD600 of 0.5), 
prior to, 10 and 60 min after the addition of 10 µg/ml C-6-
H. “RNAprotect Bacteria Reagent” (QIAGEN, Hilden, 
Table 1  Strains used in this 
study
Strain Genotype/markers Reference
SH1000 Functional rsbU+ derivative of 8325-4 Horsburgh et al. (2001)
Newman High level of clumping factor Duthie and Lorent (1952)
JLA371 SH1000 hla∷lacZ hla+ (EryR) Horsburgh et al. (2001)
SJF1293 saeS∷Tn551 (SH1000) (EryR) Needham et al. (2004)
SJF1295 saeR∷Tn551 (SH1000) (EryR) Needham et al. (2004)
Reynolds CP5 Serotype 5 prototype strain (CP5) Karakawa and Vann (1982)
Reynolds (CP−) Capsule-negative mutant of Reynolds (CP5) (EryR) Watts et al. (2005)
KC046 mrgA∷lacZ (pAZ106) (EryR) Cosgrove (unpublished)
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Germany) was added to 8 ml culture and incubated for 
5 min, and cells were harvested by centrifugation (5,000×g 
for 10 min at 4 °C) and resuspended in 1 ml RLT buffer 
(Qiagen) including 10 µg/ml β-mercaptoethanol. Cells were 
lysed using a Fast Prep shaker (BIO 101 Savant, Haarlem, 
The Netherlands) for 3× 40 s at a speed of 6.5 units. RNA 
was isolated using an “RNeasy Mini Kit 250” from QIA-
GEN. RNA quantity was measured using a NanoDrop 1000 
spectrophotometer and the quality checked by analysis 
with an Agilent 2100 Bioanalyzer (Agilent Technologies, 
Palo Alto, CA, USA). Reverse transcription and fluorescent 
labelling reactions were performed using 10 µg total RNA, 
random hexamer primers mix (Invitrogen), SuperScript 
III™ Reverse Transcriptase (Invitrogen) and incubation for 
1 h at 50 °C. The cDNA was labelled with Cy3- and Cy5-
dyed d’CTPs (Amersham) according to the manufacturer’s 
instructions (Scienion, Berlin, Germany).
RNA obtained from three independent biological experi-
ments was utilised, and a dye switch experiment was per-
formed to minimise errors based on the differential dye 
bleaching or incorporation absorption of Cy3 and Cy5 
during the RT reaction. The microarray hybridization and 
washing of the slides were carried out as recommended by 
the manufacturer (Scienion, Berlin). Microarray hybridi-
zation was at 49 °C for 48 h. The microarrays (Scienion) 
contained the full genome of S. aureus N315. Each slide 
contained PCR products of 2,334 genes in duplicate copies 
of each open reading frame (ORF) and multiple controls. 
Slides were scanned using a Genepix 4000B laser scan-
ner (Axon Instruments Inc., Union City, CA, USA), and 
the individual signal intensity was analysed using Acuity 
4.0 software, according to the manufacture’s instructions. 
Briefly, data were normalised to the mean ratio of means 
of all features, and all experiments were normalised to each 
other. Standard deviations and mean values of gene expres-
sion ratios based on the two spot replicates on each micro-
array and three different hybridisation experiments were 
calculated. Significant changes in gene expression were 
identified by a mean ratio <0.5 or >2.0 and a p value <0.05.
Real-time polymerase chain reaction (RT-qPCR)
RNA was isolated as described for the transcriptional 
analysis. Two microgram of RNA was reverse-transcribed 
to cDNA as above. Master mixes were prepared according 
to the manufacturer’s instructions, using oligonucleotides 
specific for target genes listed in Table 2. SYBR Green 
(SensiMixPlus SYBR, Quantace, London, UK) was used 
as a fluorescent nucleic acid dye. RT-qPCR was performed 
in a Mx3000P Real-Time PCR System (Stratagene), and 
the following temperature profile was used for amplifica-
tion. The initial denaturation was at 95 °C for 10 min, and 
Table 2  Oligonucleotides used for RT-PCR analysis
Oligonucleotides Sequence (5′–3′)
gyrB_QF ATCACAGCATTTGGTACAGG
gyrB_QR CGATAGAAGAATGTTAATAACAATGTT
ysxC_QF GCAGTAAAAGAAGAACAATATCC
ysxC_QR GGGTTGCTGTGATGTACG
asp23_QF AAACAACAAGAACAAAATCAAGAG
asp23_QR ACCACCTTCAACAGATACACC
hprT_QF TGTAAGGAATTGGGAGCAC
hprT_QR ACTTCACCAGTTGACTCAG
sceD_QF TCGCATCATCATTAGCAGTAG
sceD_QR GTGATAAGTAAACCCTTCATAGTC
saeS_QF GTATTGGCATTATACCAGAACTAC
saeS_QR GCGAGTTCATTAGCTATATATAAGC
saeR_QF CCAAGGGAACTCGTTTTACG
saeR_QR CATAGGGACTTCGTGACCAT
lytS_QF AAAGTTGAAAGAAGTGCATACTAAAGAAG
lytS_QR TGTACCGACGATAGAACCATG
lytR_QF ATTAGGAGCTAAGATTCAAAAGATG
lytR_QR TTGACTGCTTGTTCAATACG
lrgA_QF GCATCAAAACCAGCACACTT
lrgA_QR TGATGCAGGCATAGGAATTG
lrgB_QF TATTTGGTGTGGCCTTCCTC
lrgB_QR AAACAGATTGTTGCCGGTTC
PhoP_QF TCGGGTATTAGGTTTAGAATTAGG
PhoP_QR GGTAATATCATCGTCAATCTCTTC
PhoR_QF AATCCGTCCCATTCAAGAAGTTAC
PhoR_QR AGGCGTCGTGCTAAATCATTG
butA_QF CGTCTGAAGGTATTACTGTGAATG
butA_QR TGAGAAACTCTGCCCAAAGC
agrB_QF TCTGACGGTACTTATGTGAC
agrB_QR CCAGTGCTATTAGTTCCACTG
lytM_QF GCTATACATTCGTAGATGCTCAAG
lytM_QR CTCGCTGTGTAGTCATTGTTATC
hla_QF ATGATAGAGATTCTTGGAACCC
hla_QR AATAACTGTAGCGAAGTCTGG
katA_QF ACGAGATCCTAGAACAAATATGAG
katA_QR GTATGTGTGAGAACCGAACC
clfA_QF AATGATTCAAGTAGCGTTAGTG
clfA_QR TTCGTTGTCGTAGTAGTAGC
sarA_QF GAGTTGTTATCAATGGTCACTTATGC
sarA_QR CAGTTCTTTCATCATGCTCATTACG
cidA_QF CTACTACTACAACTAGGAATCATC
cidA_QR TTTAGCGTAATTTCGGAAGC
mrgA_QF AGTACAATCTAACATACCCACAATTTCTTG
mrgA_QR GAGTGCTAATTCAGTTACGACTTTCTTG
rsbU_QF GAAATCGTTAAAGGCTTTGGTTATAG
rsbU_QR GCTCATTGTGCCATCGTTATG
spa_QF GCAAACCATGCAGATGCTAA
spa_QR AACGCTGCACCTAAGGCTAA
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templates were amplified by 40 cycles at 95 °C for 30 s and 
54 °C for 1 min. A final step, 1 min at 95 °C, 30 s at 54 °C 
and 30 s 95 °C was used. A dissociation curve was gener-
ated to ensure amplification of a single product and absence 
of primer dimmers (Nolan et al. 2006). Three reference 
genes (gyrB, yneR and ysxC) were used which showed no 
significant change in expression on microarrays at all times 
and under all conditions. For calculation of the relative lev-
els of gene expression, only gyrB was used as the endog-
enous reference gene.
Preparation of protein extracts
For the preparation of extracellular protein extracts, cyto-
plasmic protein extracts, ionically bound proteins and 
membrane proteins, bacteria were grown in TSB−Fe (1 l) 
to exponential phase (OD600 of 1.0) and stationary phase 
(16 h).
Cells were harvested by centrifugation (9,000×g for 
10 min), and extracellular proteins from the supernatant 
were precipitated using 100 % w/v fresh TCA (10 % w/v 
final volume) and incubated on ice for 30 min. Proteins 
were harvested by centrifugation (9,000×g for 5 min), 
and the pellet was washed 5 times with 100 % v/v acetone 
and air-dried for 1.5 h. The precipitated proteins were then 
washed twice with 100 % v/v ethanol, once with 70 % v/v 
ethanol and finally with 100 % v/v ethanol, prior to air-dry-
ing the pellet overnight at room temperature (RT). Proteins 
were dissolved in urea solution (8 M urea, 2 M thiourea), 
with incubation at RT for 30 min. In order to remove insol-
uble proteins, the suspension was centrifuged for 5 min at 
20,000×g. The protein concentration was determined for 
each sample and adjusted to 200 µg protein.
For the isolation of the cytoplasmic proteins, harvested 
cells were broken by FastPrep as above and the suspen-
sion then centrifuged at 20,000×g for 10 min at 4 °C. The 
ensuing supernatant was centrifuged at 150,000×g for 
2 h at 4 °C, using an ultracentrifuge (Optima™ LE-80 K, 
Beckman, USA). The supernatant was then centrifuged as 
above, and the cytoplasmic proteins were then precipitated 
using 10 % w/v TCA and prepared as described above (for 
supernatant proteins).
Analytical and preparative 2D-PAGE
Two-dimensional polyacrylamide gel electrophoresis 
(2D-PAGE) was performed by using the immobilized pH 
gradient (IPG) technique as described previously (Bern-
hardt et al. 1999). First, protein samples were separated on 
linear IPG strips (ImmobilineTM DryStrips, GE Health-
care, Little Chalfont, UK). For extracellular and ionically 
bound protein samples, strips in the pH range 3–10 were 
used, and for cytoplasmic protein samples, the pH range 
4–7 was used. 2D gels were loaded with 200 µg protein 
extract, and the resulting gels were fixed with 50 % v/v 
ethanol and 3 % v/v acetic acid, for 30 min. Afterwards, 2D 
gels were stained with SYPRO®-Ruby and fixed with 10 % 
v/v methanol and 7 % v/v acetic acid. The stained gels 
were finally scanned using a Typhoon 9400 Variable Mode 
Imager (Amersham Biosciences, Freiburg, Germany). For 
protein identification by matrix-assisted laser desorption 
ionisation-time-of-flight mass spectrometry (MALDI-TOF-
MS), SYPRO stained protein spots were cut from gels 
using a spot cutter (Proteome Work™) with a picker head 
of 2 mm and transferred into 96-well microtiter plates. The 
proteins were digested with trypsin, and subsequent spot-
ting of peptide solutions onto MALDI targets was per-
formed automatically by using an Ettan Spot Handling 
Workstation (GE Healthcare, Little Chalfont, UK) using a 
standard protocol as previously described (Eymann et al. 
2004). Actual analyses of spotted peptide solutions were 
performed as previously described (Wolf et al. 2008).
Results and discussion
Induced resistance of S. aureus to C-6-H
To determine whether S. aureus responds to C-6-H, the 
effect of preincubation with a sub-MIC level of the fatty 
acid on resistance was determined. Firstly, to confirm the 
bactericidal effect of C-6-H, SH1000 was grown in TSB−
Fe
 to early exponential phase and challenged with 10 or 
20 µg/ml C-6-H over 2 h. We observed a rapid decrease 
in survival rate. At t = 40 min, cells treated with 10 µg/ml 
showed only 1.3 % survival and cells treated with 20 µg/ml 
C-6-H showed a survival rate of 1 % (Fig. 1). The untreated 
control showed over 55 % survival after 120 min. Con-
versely, those cells previously exposed to subgrowth inhibi-
tory level of C-6-H were much more resistant than naïve 
cells. After 1 h, 99 % of naïve cells were dead compared 
with only 12 % of those pretreated (Fig. 2). This indicates 
that S. aureus responds to C-6-H treatment by the induc-
tion of a resistance mechanism. In order to find out the 
level of C-6-H-induced resistance, additional assays were 
performed. C-6-H pretreated cells were incubated with 30, 
40, 50 and 60 µg/ml C-6-H in the killing assay (Fig. 3). 
Pretreated cells showed resistance up to 50 µg/ml C-6-H 
challenge. Challenge with 50 µg/ml C-6-H killed over 
99.9 % of naïve cells after 60 min of incubation, whereas 
pretreated cells were 80 % killed after this time. However, 
once 60 µg/ml C-6-H was used the induced resistance 
threshold was reached. There is no difference in sensitivity 
to C-6-H between the preincubated and non-preincubated 
cells (Fig. 3). Thus, a resistance mechanism is induced in 
response to C-6-H. S. aureus is an extremely adaptable 
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organism able to respond to environmental assault. Chan 
and Foster (1998) reported an increase in resistance to acid 
stress (pH 2), when the cells were pre-exposed to non-
lethal pH 4. How cells become more resistant to C-6-H is 
unknown, but no alteration in solvent partitioning by the 
cells was seen (data not shown). Cells grown in iron-lim-
ited conditions (as here) express isdA, which renders them 
hydrophilic (Clarke et al. 2007). IsdA is a major surface 
protein and has multiple roles as an adhesin, as a resistance 
determinant against human innate defences (including C-6-
H), and is required for S. aureus survival on human skin 
(Clarke et al. 2004, 2007; Clarke and Foster 2008; Clarke 
2010).
Effect of C-6-H on global gene transcription
In order to determine mechanisms involved in response to 
C-6-H, including induction of resistance and inhibition of 
virulence determinant production, transcriptional profiling 
was carried out. The expression patterns from exponen-
tial phase culture of S. aureus SH1000 with and without 
10 µg/ml C-6-H were compared. Under these conditions, 
C-6-H has no significant effect on growth rate or yield. Cul-
ture samples for analysis were taken 10 min and 60 min 
after C-6-H addition. After 10-min incubation with C-6-H, 
290 genes were decreased and 293 genes were increased 
in expression level (Table S1). Besides many genes of 
unknown function and those encoding hypothetical proteins, 
there were also many genes whose expression was altered 
by C-6-H which encode ABC transporters, bacterial secre-
tion systems, cell wall metabolism components, DNA repli-
cation and repair pathways as well as central metabolic and 
pathogenicity determinants. After 60-min incubation with 
C-6-H, 57 genes were reduced and 92 genes were increased 
in expression level compared with the untreated control 
(Table S1). These include genes encoding proteins involved 
Fig. 1  Bactericidal effect of C-6-H on strain SH1000 wt. SH1000 
was grown in TSB−Fe until OD600 0.5–0.6. Cells were harvested, 
washed with dH2O and challenged with 0 (filled circle), 10 (filled 
square) or 20 (filled triangle) µg/ml C-6-H over 2 h. Samples were 
taken, and cfu was determined over time. Samples were plated in trip-
licate, and each experiment was repeated twice. Error bars indicate 
the standard error of the mean
Fig. 2  Induced C-6-H resistance of SH1000 by pre-incubation with 
a sub-MIC of C-6-H. SH1000 was grown in TSB−Fe with or without 
10 µg/ml C-6-H until OD600 0.5–0.6. Cells were harvested, washed 
with dH2O and challenged with 0 (filled circle), 10 (filled square) or 
10 with preincubation (filled diamond) µg/ml C-6-H over 2 h. Sam-
ples were taken, and cfu was determined over time. Samples were 
plated in triplicate, and each experiment was repeated twice. Error 
bars indicate the standard error of the mean
Fig. 3  Bactericidal effect of C-6-H on cells preincubated with a sub-
MIC concentration. SH1000 was grown in TSB−Fe with (open sym-
bols) or without (filled symbols) 8 µg/ml C-6-H until OD600 0.5–0.6, 
as described in chapter 2. Cells were harvested, washed with dH2O 
and challenged with 30 (open square, filled square), 40 (open tri-
angle, filled triangle), 50 (open circle, filled circle) or 60 (open dia-
mond, filled diamond) µg/ml C-6-H. Samples were taken, and cfu was 
determined over time. Samples were plated in triplicate, and each 
experiment was repeated twice. Error bars indicate the standard error 
of the mean
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in ABC transporter systems, metabolism of coenzymes and 
prosthetic groups, amino acid synthesis, stress response and 
many genes involved in virulence of S. aureus.
Effects of C-6-H on purine and pyrimidine biosynthesis
The greatest decrease in expression after 10-min C-6-H incu-
bation was shown by genes encoding proteins involved in 
purine and pyrimidine biosynthesis (Table S1). In particular, 
pyrR, pyrP, pyrB, pyrC, pyrAA, pyrAB, pyrF and pyrE of the 
de novo pyrimidine metabolism were significantly down-reg-
ulated (spot vol. ratio 0.09 ± 0.04) in the presence of C-6-H 
compared with the control. This whole operon is regulated 
by pyrR and strongly depends on the presence of pyrimidine 
nucleotides (Turner et al. 1994; Paulus et al. 1982). Synthe-
sis of pyrimidine is crucial for the cells to divide and there-
fore cell survival (Turnbough and Switzer 2008). The regula-
tor pyrR showed a decrease in expression (spot vol. ratio of 
0.06) in the presence of C-6-H (10-min incubation). Interest-
ingly, after 60-min incubation with C-6-H, the operon pyrR-
E (SA1041–SA1048) was highly increased in expression 
(Table S1). The regulator pyrR is increased in expression 
(spot vol. ratio 19.6), and genes pyrP, pyrB, pyrC and pyrAB 
were even more (spot vol. ratio 25 ± 5) up-regulated in 
expression, suggesting that the rapid response (10 min) of S. 
aureus to C-6-H may alter the intracellular pyrimidine pool, 
thus requiring increased expression of the genes after the ini-
tial adaptation period. Interestingly, the response to C-6-H 
may be specific as Kenny et al. (2009) reported no effect 
of linoleic or oleic acid on expression of genes involved in 
pyrimidine biosynthesis. How C-6-H and other fatty acids 
effect bacteria and differential responses alludes to fatty 
acid-specific mechanisms.
Genes that are involved in purine metabolism such as 
xprT (xanthine phosphoribosyltransferase), guaA (GMP 
synthase), guaB (inositol-monophosphate dehydrogenase) 
and relA(rsh) (GTP pyrophosphokinase) also showed a 
strong decrease in expression in the presence of C-6-H 
after 10-min incubation (spot vol. ratio 0.3 ± 0.2) (Table 
S1). After 60-min C-6-H incubation, the expression of 
xprT, guaA, guaB but not relA was still decreased. Interest-
ingly, RelA as well as enzymes of the purine biosynthetic 
pathway has been described to be involved in resistance to 
lysostaphin (Gründling et al. 2006). Further, RelA (Rsh) 
may be important in the response to C-6-H as it effects the 
expression of a number of genes, including cap (via CodY) 
(Geiger et al. 2010; Pohl et al. 2009; Srivatsan and Wang 
2008; Wolz et al. 2010).
Effects of C-6-H on cellular transport systems
The microarray data demonstrated that many genes encod-
ing for ABC transporters were effected in expression in 
the presence of C-6-H. Two genes, cbiO (Cobalt import 
ATP-binding protein Cibo1) and cibO2 (Cobalt import 
ATP-binding protein CibO2), which are part of the cobalt 
transporter, are decreased in expression. After 10-min incu-
bation with C-6-H, microarray data showed a spot vol. ratio 
of 0.42 and 0.49. Cobalt is an essential cofactor for several 
enzymes and other components such as vitamin B12 and 
must be imported into the cell (Kobayashi and Shimizu 
1999). Surprisingly, other genes involved in cobalt trans-
port such as cbiQ (transmembrane component) and cbiN 
(small membrane-bound component) were not affected in 
expression by C-6-H. After 60-min incubation with C-6-H, 
the cbiO genes showed no change in expression compared 
with the control (Table S1).
The expression of three genes, potA, potB and potC, 
from the potABCD operon were down-regulated after 
10-min C-6-H incubation with a spot vol. ratio of 
0.28 ± 0.05. After 60-min incubation with C-6-H, the 
expression of genes from the potABCD operon showed no 
change compared with the control. The operon encodes an 
ABC transporter that transports polyamines such as putres-
cine and spermidine across the membrane. Polyamines play 
an important role in cell proliferation and differentiation, as 
shown in E. coli (Kashiwagi et al. 1993).
Interestingly, the genes encoding for a putative mono-
valent cation/H+ antiporter were increased in expression 
in the presence of C-6-H (spot vol. ratio of 2.1 ± 0.1). 
SA0578 (putative antiporter subunit A), SA0579 (putative 
antiporter subunit B), SA0580 (putative antiporter subunit 
C), SA0581 (putative antiporter subunit D), SA0583 (puta-
tive antiporter subunit E) and SA0584 (putative antiporter 
subunit F) may be part of a Na+/H+ antiporter which is 
involved in resistance to high concentrations of K+, Li+ 
and Na+ ions. Antiporters play an important role in cir-
culating Na+ and H+ across the cytoplasmic membrane 
(Padan and Schuldiner 1994) and are also important for the 
internal pH maintenance. Recently, we reported the bac-
tericidal mechanisms of C-6-H at different concentrations 
(Cartron et al. 2014). C-6-H has multiple effects on the cell 
membrane including loss of the ability to maintain intracel-
lular pH.
Compared with the genes that were affected after 10-min 
incubation, a completely different set was affected (posi-
tively as well as negatively) in expression after incubation 
with C-6-H for 60 min. The array data revealed that the 
genes sirA, proP, fhuA, glpF and SA2339 were increased 
in expression by C-6-H incubation. Interestingly, the gene 
SA2339 is highly up-regulated (spot vol. ratio over 11) in 
expression in the presence of C-6-H. SA2339 is, according 
to the database (NCBI), a hypothetical protein which shows 
similarities to an antibiotic transport-associated protein. 
The sirA gene (staphylococcal iron regulator) encodes for 
a lipoprotein, and the microarray data revealed a spot vol. 
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ratio of 2.9, only after 60-min C-6-H incubation. The sirA 
gene is part of the operon sirABC. Heinrichs et al. (1999) 
reported that SirA acts as a membrane-associated sidero-
phore-binding protein. The operon is iron regulated, and 
transcription is controlled by the Fur protein (Heinrichs et 
al. 1999). Interestingly, the regulatory gene fur showed a 
down-regulation (spot vol. ratio 0.48) after 10-min incuba-
tion with C-6-H. The fur gene encodes for the ferric uptake 
regulator which controls cellular iron homoeostasis (Hors-
burgh et al. 2001).
Furthermore, the gene fhuA (ferrichrome transport ATP-
binding protein) was increased in expression after 60-min 
C-6-H incubation (spot vol. ratio 2.4). The fhuA gene is 
part of the fhu system which encodes for a ferric hydroxa-
mate uptake system and therefore involved in iron acquisi-
tion from hydroxamate siderophore (Sebulsky et al. 2000). 
Interestingly, none of the other genes that belong to the fhu 
system were affected in expression by C-6-H. The fhuD2 
gene (spot vol. ratio 3.9) showed an increase in expres-
sion after 60-min C-6-H treatment. Sebulsky et al. (2003) 
reported that fhuD2 encodes an iron (III)-siderophore-
binding protein. After binding a siderophore, the FhuD2–
siderophore complex will be recognised by the Fhu system. 
Iron is one of the most important nutrients for S. aureus 
and is required for various key metabolic processes. Its 
acquisition is vital for survival. The sirABC operon as well 
as the fhu genes is crucial components in the iron acquisi-
tion process.
The gene proP, which encodes for a proline/betaine 
transporter homologue (MacMillan et al. 1999), was 
increased (spot vol. ratio 2.4) in expression in the pres-
ence of C-6-H at 60 min only (Table S1). This transporter 
is important in balancing osmotic differences between S. 
aureus and its environment. The proP gene is part of the 
VraSR regulon, which includes 13 genes in total and is 
involved in regulation of the cell wall biosynthesis pathway 
(Kuroda et al. 2003).
Effects of C-6-H on the cell envelope and cell wall 
synthesis
The expression of many genes involved in cell envelope 
biogenesis, including lytM, dltABD, cidA, pbp2 and pbp4, 
was altered in response to C-6-H treatment. The pepti-
doglycan hydrolase LytM (autolysin) plays a role in cell 
wall turnover as well as cell division (Ramadurai et al. 
1999). After 10-min incubation with C-6-H, the expression 
of lytM was decreased (spot vol. ratio 0.48) in expression, 
whereas after 60-min incubation no change in expression 
was observed. LytM hydrolyses peptidoglycan, and it has 
been proposed that it might play a role in the lysis of cells 
initiated by cell wall-acting antibiotics (Kusser and Ishig-
uro 1988), suggesting that C-6-H may induce lysis.
Genes of the dltABCD operon, which is important 
for d-alanylation of wall teichoic acids (WTA) as well as 
lipoteichoic acids (LTA), showed a strong decrease in 
expression in the presence of C-6-H after 10-min treatment. 
After 60-min C-6-H incubation, no change in expression of 
the dltABCD was observed. The dltA gene (spot vol. ratio 
0.15) encodes a d-Alanyl carrier protein ligase and activates 
d-alanine using ATP. Also, dltB, a predicted transmembrane 
protein, and dltD, a membrane protein (Neuhaus and Bad-
diley 2003), showed a spot vol. ratio of 0.25 ± 0.02. Sur-
prisingly, dltC expression showed no effect of C-6-H in the 
microarray data. Koprivnjak et al. (2006) reported that the 
dltABCD operon is highly repressed by a rising concentra-
tion of monovalent and divalent (Mg2+) cations. This group 
also mentioned that the transcriptional regulation may be 
partly due to the ArlSR two-component system. (Koprivn-
jak et al. 2006)
Weidenmaier et al. (2005) reported the role of the 
dltABCD operon in mediating resistance to cationic 
antimicrobial peptides (CAMP). DltABCD is able to 
modify negatively charged cell envelope components 
with positively charged amino acids, to enhance the net 
positive surface charge of S. aureus leading to CAMP 
resistance (Peschel 2002). The down-regulation (due 
to C-6-H) of dltABD expression may affect surface 
charge. Kohler et al. (2009) showed that wall teichoic 
acids, which play an important role in S. aureus surface 
charge, are crucial for protection of S. aureus against 
human skin fatty acids such as C-6-H. However, the 
treatment with C-6-H showed a strong decrease in 
expression of the dltABCD operon within the first few 
minutes but then recovers.
Penicillin-binding proteins 2 and 4 had altered expres-
sion (spot vol. ratios of 2.04 and 0.46, respectively) after 
10-min incubation with C-6-H. PBP2 is involved in cell 
wall metabolism and methicillin resistance (Giesbrecht et 
al. 1998), and PBP4 is mainly involved in secondary cross-
linking of the peptidoglycan layer (Henze and Berger-
Bachi 1996), further suggesting that the cell wall of S. 
aureus is involved in protection against fatty acids.
The regulator lytSR, which encodes for a sensor histidine 
kinase (LytS) and a response regulator (LytR), was reduced 
(spot vol. ratio 0.38 ± 0.04) after 10-min C-6-H incubation 
(Table S1). LytSR is a sensor–regulator system with both 
positive and negative regulatory effects on murein hydro-
lase activity and autolysis (Brunskill and Bayles 1996). It 
is proposed that LytSR is able to sense a decrease in mem-
brane potential and initiates the transcription of lrgAB (Pat-
ton et al. 2006; Bayles 2007). The lrgAB genes are involved 
in the regulation of murein hydrolase activity and may play 
a role in autolysin regulation (Groicher et al. 2000; Bayles 
2003). Further studies reported that the cidA gene encodes 
for a holing-like membrane protein that is an effector of 
252 Arch Microbiol (2015) 197:245–267
1 3
murein hydrolase activity and cell lysis, whereas lrgA 
encodes an antiholin that is an inhibitor of CidA (Groicher 
et al. 2000; Rice et al. 2003). Interestingly, the array data 
showed that the expression of lrgAB is highly increased 
after 10-min incubation with C-6-H (spot vol. ratios of 89 
and 20, for lrgA and lrgB, respectively) (Table S1) even if 
its regulatory activator (lytSR) is inhibited in expression by 
C-6-H. LrgA and LrgB are involved in regulation of pepti-
doglycan hydrolase activity by reducing extracellular activ-
ity (Groicher et al. 2000; Bayles 2003). Bayles (2007) sug-
gested that LrgAB together with their antagonist proteins 
CidAB was involved in the control of bacterial death and 
lysis during biofilm formation. Interestingly, the expression 
of cidA was decreased after 10-min C-6-H incubation (spot 
vol. ratio over 4). The cidA gene is in an operon with cidB. 
The cidB gene showed no change in expression levels in 
the presence of C-6-H, but cidA was decreased in expres-
sion and cidC was increased in its expression, respectively.
Further, Rice et al. (2003) showed that a lytSR muta-
tion leads to an increase in autolysis rate and a decrease 
in lrgAB expression. These data were confirmed when 
Sharma-Kuinkel et al. (2009) reported that a mutation in 
the lytS gene showed a drastic decrease in the expression 
of lrgAB operon. Interestingly, in this study, the expres-
sion of lytSR showed a decrease in its transcription in the 
presence of C-6-H and the expression of the lrgAB operon 
was highly increased in its expression, suggesting that there 
might be an additional so far unknown regulatory system 
involved in lrgAB control.
We have observed that the bactericidal activity of C-6-H 
occurs via a variety of mechanisms, including loss of pro-
ton motive force (PMF) (Cartron et al. 2014), which may 
lead to an increase in lytSR expression.
The biological role of the lrg and cid operons has been 
suggested to be in the control of cell death and lysis dur-
ing biofilm formation, as well as release of genomic DNA 
to promote intracellular adhesion in biofilm stability (Bay-
les 2007). The increased lrgAB expression and decreased 
expression of cidA may be due to cell wall stress and is a 
response that may prevent cell death due to metabolic per-
turbation. In a separate study, Kenny et al. (2009) observed 
a decrease of lrgA expression in response to linoleic acid, 
which demonstrates distinct responses to specific unsatu-
rated long-chain fatty acids by S. aureus.
Capsule biosynthesis genes (cap) showed a significant 
increase in expression (spot vol. ratio of 2.4–7) (Table 
S1). The capsule is involved in the pathogenicity of S. 
aureus by preventing phagocytosis and killing by mac-
rophages (O’Riordan and Lee 2004). Thus, it was possible 
that the capsule may represent a C-6-H resistance mecha-
nism. Strain SH1000 is not highly encapsulated, and so 
the role of capsule was determined using strain Reynolds. 
Killing assays using strain Reynolds and corresponding 
cap strains did not show any significant differences 
in C-6-H susceptibility (data not shown). Kenny et al. 
(2009) also observed an increase in cap gene expression 
in response to linoleic acid by strain MRSA252. As the 
capsule has an antiphagocytic effect, it may be that host-
associated stresses (such as C-6-H) lead to its induction as 
a general response.
Effects of C-6-H on the expression of virulence 
determinants
Clarke et al. (2007) have previously reported a decrease 
in toxin production in response to C-6-H. The microarray 
data revealed altered expression of many genes involved 
in pathogenicity. After incubation with C-6-H, virulence-
associated genes such as nuc, hla, hlb, rsbU, sarZ, sarA, 
clfA and two-component regulator saeRS were effected in 
expression (Table S1).
The thermonuclease (nuc) is an extracellular protein 
that degrades double- and single-stranded DNA and RNA. 
After 10-min incubation with C-6-H, the expression of 
nuc was decreased (spot vol. ratio 0.3), but after 60-min 
treatment with C-6-H the expression of nuc was increased 
(spot vol. ratio 2.4). The degradation of extracellular DNA 
plays an important role in host immune evasion to escape 
from neutrophils extracellular traps (NETs) (Berends et al. 
2010).
Besides, the two-component regulator saeRS that 
encodes for a histidine kinase and a response regulator 
was affected by -6-H (Giraudo et al. 1999). After 10-min 
incubation with C-6-H, the expression of saeRS genes was 
decreased (spot vol. ratio 0.4). Novick and Jiang (2003) 
reported two additional ORFs in the SaeRS system, saeP 
and saeQ, which are likely to be important for the func-
tion of the operon (Adhikari and Novick 2008; Geiger et 
al. 2008). The saeP gene, but not saeQ, was decreased 
in expression (spot vol. ratio 0.28) after incubation with 
C-6-H for 10 min.
Previous reports have shown that SaeRS activates the 
expression of α-haemolysin (hla), β-haemolysin (hlb), 
fibronectin-binding protein (fnbA and fnbB), protein A 
(spa), coagulase (coa), thermonuclease (nuc), extracellular 
adherence protein Eap, IgG-binding protein (sbi) and extra-
cellular matrix-binding protein Emp (Giraudo et al. 1994, 
1997; Goerke et al. 2001, 2005; Harraghy et al. 2005). Fur-
thermore, it represses the expression of V8 serine protease 
(sspA) and capsular polysaccharide (type 5) (cap5). As 
many of those virulence determinants (e.g. hla, hlb, fnbA, 
nuc) were decreased in expression due to C-6-H, this may 
be due to the activity of SaeRS (Table S1).
There was differential expression of surface proteins in 
response to C-6-H. Clumping factor A (clfA), a fibrinogen-
binding protein, showed a high increase in expression after 
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10-min C-6-H incubation (spot vol. ratio 6.5). The ClfA 
protein plays an important role in the adhesion to host cells 
(McDevitt et al. 1994) and is responsible for clumping in 
host blood plasma (McDevitt et al. 1997). Kenny et al. 
(2009) reported a similar observation, where clfA expres-
sion is up-regulated. Interestingly, the surface protein-
encoding genes fnbA and fnbB were decreased in expres-
sion by C-6-H. FnbA and B are cell surface-associated 
proteins which mediate the attachment to host cells (e.g. 
endothelial cells) and can also act during invasion (Peacock 
et al. 1999; Xu et al. 2008).
As already reported, the hla and hlb genes were highly 
decreased in expression after 60-min C-6-H incubation 
(spot vol. ratio 0.11 ± 0.02). These encode the major tox-
ins α-haemolysin (hla) and β-haemolysin (hlb), which 
are membrane-damaging molecules, expressed in post-
exponential phase, and are important for spreading into 
new host tissues (Bhakdi and Tranum-Jensen 1991). The 
effect of C-6-H on hla expression was expected as earlier 
reports have shown that fatty acids (e.g. glycerol monolau-
rate (GML) were able to inhibit the expression of virulence 
determinants in S. aureus (Schlievert et al. 1992; Projan et 
al. 1994). Clarke et al. (2007) found that C-6-H is able to 
inhibit the expression of α-haemolysin (hla) and protein 
A (spa) at the transcriptional level. Since no change in 
RNAIII expression (agr, the main regulator of virulence 
Table 3  Effect of C-6-H on expression of genes determined by qRT-PCR
ORF N315 Gene Gene product Fold change RT-PCR Spot vol ratio 
(microarray)
10 min 60 min 10 min 60 min
Cell envelope and cell wall
 SA0252 IrgA Holin-like protein LrgA 5.00 0.27 89.97 1.00
 SA0253 IrgB Holin-like protein LrgB 4.00 0.43 20.73 1.00
 SA0265 IytM Peptidoglvcan hydrolase 1.00 3.00 0.49 1.00
 SA2329 cidA Holin-like protein CidA 0.23 1.00 0.22 1.00
Virulence factors and regulators
 SA0250 lytS Two-component sensor histidine kinase 0.44 1.00 0.43 1.00
 SA0251 lytR Two-component response regulator 1.00 1.00 0.35 1.00
 SA0573 sarA Staphylococcal accessory regulator A 2.00 1.00 2.37 1.00
 SA0660 saeS Histidine protein kinase 1.00 1.00 0.44 1.00
 SA0661 saeR Response regulator 1.00 1.00 0.41 1.00
 SA0742 clfA Fibrinogen-binding protein A, clumping factor 1.00 1.00 6.54 1.00
 SA1007 hla Alpha-haemolysin 0.41 0.07 1.00 0.13
 SA1842 agrB Accessory gene regulator B 3.00 1.00 1.00 1.00
 SA1872 rsbU SigmaB regulation protein RsbU 1.00 1.00 0.49 1.00
Stress response
 SA1170 katA Catalase 3.00 1.00 5.06 1.00
 SA1984 asp23 Alkaline shock protein 23, ASP23 1.00 1.00 7.52 1.00
Butanoate metabolism
 SAO122 butA Acetoin reductase 5.00 1.00 16.89 2.72
 Transcriptional regulator
 SA0641 mrzA HTH-type transcriptional regulator MgrA (NorA) 1.00 1.00 0.50 1.00
 SA1515 phoR Alkaline phosphatase synthesis sensor protein 1.00 1.00 1.00 1.00
 SA1516 phoP Alkaline phosphatase synthesis transcriptional regulation 1.00 1.00 3.31 1.00
Purine and/ or pyrimidine metabolism
 SA0468 hprT Hypoxanthine-guanine phosphoribosyltransferase homologue 1.00 1.00 0.29 1.00
Unknown functions and hypothetical proteins
 SA1898 sceD Hypothetical protein, similar to SceD precursor 1.00 3.00 1.00 3.18
Housekeeping genes
 SA0005 gyrB DNA gyrase subunit B 1.00 1.00 1.00 1.00
 SA1186 Hypothetical protein, homologue toyneS from B. subtilis 1.00 1.00 1.00 1.00
 SA1497 ysxC Ribosome biogenesis GTP-binding protein YsxC 1.00 1.00 1.00 1.00
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factors) has been observed after the exposure to C-6-H or 
GML, it leads to the suggestion that the effect of C-6-H on 
the expression of virulence determinants is due to another 
regulatory system (Projan et al. 1994; Clarke et al. 2007). 
In contrast, Kenny et al. (2009) observed that the expres-
sion of hla and spa was up-regulated after exposure of 
MRSA252 to linoleic or oleic acid.
The expression of sbi (IgG-binding protein) was nega-
tively affected by C-6-H (spot vol. ratio 0.09 and 0.18 and 
after 10- and 60-min incubation, respectively). Sbi has an 
important role in adherence to host cells during the infec-
tive process and acts similarly to protein A (Zhang et al. 
1998).
Effects of C-6-H on general intracellular processes
Microarray data revealed altered expression of genes 
involved in carotenoid biosynthesis. The genes crtN 
(squalene desaturase), crtM (squalene synthase), crtQ 
(putative glycosyl transferase), crtP (4,4′-diaponeuro-
sporene oxidase) and SA2352 (hypothetical protein) were 
increased in expression after incubation for 10 min with 
C-6-H (spot vol. ratio 3.7 ± 1.7). It has been reported 
that there is a direct correlation between carotenoid pro-
duction and cell membrane fluidity (Chamberlain et al. 
1991; Mishra et al. 2009). The carotenoids insert into 
the membrane and increase its rigidity, which could lead 
to its stabilization in response to C-6-H. Previous stud-
ies reported that long-chain unsaturated fatty acids could 
lead to an increase in membrane fluidity (Chamberlain 
et al. 1991). In the presence of the fatty acid C-6-H, the 
transcriptome data also showed an increase in expression 
of genes involved in fatty acid biosynthesis (fabD, fabG, 
acpP) after 60-min challenge conditions with C-6-H 
(spot vol. ratio 2.1 ± 0.1) (Table S1). The synthesis of 
fatty acids is essential for membrane phospholipid for-
mation and stability, suggesting that S. aureus responds 
to the potential loss of membrane integrity due to C-6-H 
by increasing the expression of genes involved in fatty 
acid biosynthesis.
Several genes involved in stress responses were affected 
in expression by C-6-H incubation. The katA gene encodes 
catalase and is increased in expression only after 10-min 
incubation with C-6-H (spot vol. ratio 5). It is important 
for S. aureus for neutralisation of H2O2, survival and nasal 
colonisation (Cosgrove et al. 2007).
The microarray data revealed that genes of the Clp 
family (clpC, clpB and clpL) were increased in expres-
sion in the presence of C-6-H (spot vol. ratio 2.4, 3.7 and 
13.1, respectively). ClpC is a chaperone with ATPase 
activity, and together with ClpB, it is highly induced 
during thermal stress with a function to degrade heat-
damaged proteins, as well as an important role in biofilm 
formation (Becker et al. 2001; Frees et al. 2003). ClpB 
is required for growth at high temperature (Frees et al. 
2003). ClpL is also an ATP-dependent proteinase and is 
important in the thermotolerance of S. aureus (Frees et 
al. 2003).
In response to C-6-H, there is an up-regulation of ure-
ase (ureA-G) expression (60-min incubation, spot vol. ratio 
4 ± 2, Table S1). Urease is involved in hydrolysing urea 
into NH3 (ammonia) and CO2 (carbon dioxide) as a nitro-
gen source and acid resistance.
The transcription of dhoM (homoserine dehydroge-
nase), thrC (threonine synthetase) and thrB (homoserine 
kinase) was increased after incubation with C-6-H for 
10 min (spot vol. ratio 7.5 ± 3.5) and for 60 min (spot vol. 
ratio 3.1 ± 0.2). All three proteins are important for amino 
acid synthesis such as serine, glycine or threonine. ThrC 
catalyses the last reaction of threonine synthesis from 
asparate.
Real-time PCR (RT-PCR)
The transcriptome data of selected genes were validated 
using RT-PCR (Table 3), whereas all samples were ampli-
fied in triplicate. The focus was on genes involved in viru-
lence and stress response. The RT-PCR analysis showed 
that hla was 20-fold down-regulated after 60-min incu-
bation with C-6-H. For the genes lrgA, lrgB, katA, sarA, 
sceD, cidA, lytS and butA, RT-PCR data also confirmed the 
microarray results, verifying the high impact of C-6-H on 
the expression of those genes. However, not all qRT-PCR 
data are in correlation with the effect of C-6-H observed in 
the microarray data. For spa, hprT, phoP, asp23, lytR and 
saeRS, no effect on expression due to C-6-H was observed 
(Table 3). This demonstrates that multiple approaches 
Fig. 4  Effect of C-6-H on hla expression in saeRS mutant strains. S. 
aureus SH1000 wt, SH1000 saeS∷Tn551 and SH1000 saeR∷Tn551 
were grown in TSB−Fe until OD600 0.5. 8 µg/ml C-6-H was added 
to the cultures, and cells were incubated for 10 (striped bars) or 60 
(filled bars) min. Total mRNA was isolated, and an qRT-PCR experi-
ment was performed determining hla expression. Red line shows sig-
nificant change of at least 0.5-fold. The samples were measured in 
triplicate, and qRT-PCR experiment was carried out three times
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Table 4  Growth phase associated changes in extracellular protein profile
ORF N315 Protein Gene product OD 1.0 versus 16 h Spot ID
SA0009 SerS Seryl-tRNA synthetase 0.65 331
SA0091 Plc 1-Phosphatidylinositol phosphodiesterase precurosr 2.29 563
SA0091 Plc 1-Phosphatidylinositol phosphodiesterase precurosr 4.83 565
SA0091 Plc 1-Phosphatidylinositol phosphodiesterase precurosr 38.19 571
SA0128 SodM (SodA1) Superoxide dismutase 1.60 698
SA0131 Pnp (DeoD1) Purine nucleoside phosphorylase 1.11 654
SA0131 Pnp (DeoD1) Purine nucleoside phosphorylase 0.06 187
SA0162 AldA Aldehyde dehydrogenase homologue 0.27 294
SA0182 Hypothetical protein, similar to indole-3-pyruvate decarboxylas 1.12 280
SA0265 LytM Peptidoglycan hydrolase 0.15 454
SA0265 LytM Peptidoglycan hydrolase 0.13 460
SA0309 Geh Glycerol ester hydrolase 2.29 170
SA0309 Geh Glycerol ester hydrolase 3.08 171
SA0309 Geh Glycerol ester hydrolase 2.84 172
SA0309 Geh Glycerol ester hydrolase 1.81 175
SA0309 Geh Glycerol ester hydrolase 4.03 177
SA0309 Geh Glycerol ester hydrolase 9.64 199
SA0309 Geh Glycerol ester hydrolase 3.28 212
SA0309 Geh Glycerol ester hydrolase 1.76 224
SA0309 Geh Glycerol ester hydrolase 21.07 229
SA0309 Geh Glycerol ester hydrolase 5.23 272
SA0309 Geh Glycerol ester hydrolase 1.81 282
SA0309 Geh Glycerol ester hydrolase 0.83 421
SA0309 Geh Glycerol ester hydrolase 2.75 433
SA0309 Geh Glycerol ester hydrolase 0.57 439
SA0309 Geh Glycerol ester hydrolase 3.00 443
SA0309 Geh Glycerol ester hydrolase 1.20 451
SA0309 Geh Glycerol ester hydrolase 1.90 176
SA0309 Geh Glycerol ester hydrolase 1.17 217
SA0309 Geh Glycerol ester hydrolase 3.97 221
SA0309 Geh Glycerol ester hydrolase 0.68 238
SA0309 Geh Glycerol ester hydrolase 2.99 248
SA0309 Geh Glycerol ester hydrolase 1.32 259
SA0309 Geh Glycerol ester hydrolase 1.97 293
SA0309 Geh Glycerol ester hydrolase 3.40 418
SA0309 Geh Glycerol ester hydrolase 8.89 424
SA0309 Geh Glycerol ester hydrolase 5.58 435
SA0309 Geh Glycerol ester hydrolase 1.15 436
SA0366 AhpC Alkyl hydroperoxide reductase subunit C 3.04 712
SA0375 GuaB Inositol-monophosphate dehydrogenase 0.34 308
SA0376 GuaA GMP synthase 2.00 274
SA0382 Set6 Superantigen-like protein 0.03 706
SA0482 Putative ATP: guanido phosphotransferase SA0482 0.76 366
SA0486 GltX Glutamyl-tRNA synthetase 1.21 289
SA0486 GltX Glutamyl-tRNA synthetase 0.41 302
SA0488 CysS Cysteinyl-tRNA synthetase 0.64 309
SA0505 FusA Elongation factor G 0.14 162
SA0506 Tuf Elongation factor Tu 0.69 371
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Table 4  continued
ORF N315 Protein Gene product OD 1.0 versus 16 h Spot ID
SA0506 Tuf Elongation factor Tu 0.63 396
SA0544 Putative haem peroxidase 0.21 618
SA0587 Lipoprotein, streptococcal adhesin PsaA homologue 1.63 561
SA0587 Lipoprotein, streptococcal adhesin PsaA homologue 0.22 610
SA0620 Secretory antigen SsaA homologue 0.28 626
SA0674 Glycerol phosphate lipoteichoic acid synthase 0.87 336
SA0674 Glycerol phosphate lipoteichoic acid synthase 0.53 343
SA0674 Glycerol phosphate lipoteichoic acid synthase 1.15 344
SA0674 Glycerol phosphate lipoteichoic acid synthase 0.70 346
SA0674 Glycerol phosphate lipoteichoic acid synthase 0.50 353
SA0686 NrdE Ribonucleotide-diphosphate reductase subunit alpha 0.51 189
SA0719 TrxB Thioredoxin reductase 1.82 508
SA0727 Gap Glyceraldehyde-3-phosphate dehydrogenase 0.54 447
SA0728 Pgk Phosphoglycerate kinase 0.57 409
SA0731 Eno Phosphopyruvate hydratase 0.55 384
SA0732 ClpP ClpP 1.07 729
SA0775 Hypothetical protein 0.52 296
SA0787 IS1181 transposase 0.37 242
SA0802 NADH dehydrogenase-like protein SA0802 0.94 411
SA0820 GlpQ Glycerophosphoryl diester phosphodiesterase 2.31 569
SA0820 GlpQ Glycerophosphoryl diester phosphodiesterase 1.72 570
SA0823 Pgi Glucose-6-phosphate isomerase 1.10 378
SA0829 Hypothetical protein 0.16 573
SA0831 Cdr Coenzyme A disulphide reductase 2.08 349
SA0842 FabH FabH, 3-oxoacyl-(acyl carrier protein) synthase homologue 1.04 489
SA0843 Fab (FabF) 3-oxoacyl-synthase 0.94 362
SA0900 SspB1 Cysteine protease precursor SspB 1.72 427
SA0900 SspB1 Cysteine protease precursor SspB 1.25 432
SA0900 SspB1 Cysteine protease precursor SspB 2.53 468
SA0900 SspB1 Cysteine protease precursor SspB 1.51 825
SA0901 SspA V8 protease 0.77 474
SA0901 SspA V8 protease 1.26 478
SA0901 SspA V8 protease 1.30 483
SA0901 SspA V8 protease 1.73 486
SA0901 SspA V8 protease 0.39 507
SA0901 SspA V8 protease 1.47 511
SA0901 SspA V8 protease 1.37 490
SA0904 Atl ATL autolysin transcription regulator 0.28 163
SA0908 Hypothetical protein 1.80 417
SA0908 Hypothetical protein 1.90 419
SA0935 PtsI Phosphoenolpyruvate-protein phosphatase 0.09 244
SA0939 Hypothetical protein 0.12 676
SA0945 PdhC Branched-chain alpha-keto acid dehydrogenase subunit E2 0.47 192
SA0946 PdhD Dihydrolipoamide dehydrogenase 1.04 287
SA1007 Hla Alpha-haemolysin 5.28 531
SA1007 Hla Alpha-haemolysin 2.71 536
SA1007 Hla Alpha-haemolysin 5.04 539
SA1007 Hla Alpha-haemolysin 4.60 541
SA1007 Hla Alpha-haemolysin 1.92 651
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Table 4  continued
ORF N315 Protein Gene product OD 1.0 versus 16 h Spot ID
SA1036 IleS Isoleucyl-tRNA synthetase 0.41 132
SA1098 CodY Transcriptional repressor CodY 2.87 617
SA1099 RpsB 30S ribosomal protein S2 0.55 514
SA1100 Tsf Elongation factor Ts 2.23 459
SA1100 Tsf Elongation factor Ts 1.58 470
SA1128 RecA Recombinase A 0.79 389
SA1150 GlnA Glutamine–ammonia ligase 1.70 323
SA1170 KatA Catalase 1.87 263
SA1177 Tkt Transketolase 0.40 197
SA1177 Tkt Transketolase 1.31 201
SA1177 Tkt Transketolase 3.11 401
SA1533 AckA Acetate kinase homologue 0.40 393
SA1184 CitB (AcnA) Aconitate hydratase 0.23 128
SA1216 PepF Hypothetical protein, similar to oligoendopeptidase 33.50 215
SA1283 Pbp2 PBP2 0.57 220
SA1308 RpsA 30S ribosomal protein S1 0.43 363
SA1336 Glucose-6-phosphate 1-dehydrogenase 1.50 250
SA1342 Gnd 6-Phosphogluconate dehydrogenase 2.22 391
SA1342 Gnd 6-Phosphogluconate dehydrogenase 2.20 400
SA1359 Efp Elongation factor P 0.40 560
SA1409 DnaK Molecular chaperone DnaK 0.69 226
SA1409 DnaK Molecular chaperone DnaK 2.15 546
SA1499 Tig Trigger factor 0.10 231
SA1520 PykA Pyruvate kinase 0.68 203
SA1529 Metal-dependent hydrolase 6.88 669
SA1553 Fhs Formate-tetrahydrofolate ligase 2.57 273
SA1553 Fhs Formate-tetrahydrofolate ligase 1.16 277
SA1579 LeuS Leucyl-tRNA synthetase 2.68 143
SA1599 Tal Hypothetical protein, similar to transaldolase 1.17 659
SA1609 PckA Phosphoenolpyruvate carboxykinase 2.05 279
SA1627 SplF Serine protease SplE, putative 2.93 667
SA1627 SplF Serine protease SplE, putative 7.46 660
SA1627 SplF Serine protease SplE, putative 7.88 670
SA1628 SplD Serine protease SplD 4.68 666
SA1629 SplC Serine protease SplC 4.43 656
SA1629 SplC Serine protease SplC 1.41 657
SA1630 SplB Serine protease SplB 6.64 646
SA1631 SplA Serine protease SplA 4.55 642
SA1631 SplA Serine protease SplA 2.01 647
SA1637 LukD Leukotoxin, LukD 1.22 487
SA1653 TRAP Signal transduction protein TRAP 6.36 914
SA1695 AmpS Aminopeptidase ampS 1.34 397
SA1709 Ferritin 0.32 910
SA1725 SspB2 Staphopain, cysteine proteinase 1.76 725
SA1725 SspB2 Staphopain, cysteine proteinase 6.01 754
SA1811 Hlb Beta-haemolsysin 1.28 505
SA1811 Hlb Beta-haemolsysin 1.02 509
SA1811 Hlb Beta-haemolsysin 0.38 515
SA1811 Hlb Beta-haemolsysin 5.31 519
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Table 4  continued
ORF N315 Protein Gene product OD 1.0 versus 16 h Spot ID
SA1811 Hlb Beta-haemolsysin 2.31 520
SA1811 Hlb Beta-haemolsysin 0.29 522
SA1811 Hlb Beta-haemolsysin 0.65 574
SA1812 Uncharacterized leukocidin-like protein 1 precursor 1.64 499
SA1812 Uncharacterized leukocidin-like protein 1 precursor 2.19 500
SA1812 Uncharacterized leukocidin-like protein 1 precursor 1.21 502
SA1813 Uncharacterized leukocidin-like protein 2 precursor 0.72 494
SA182 SodA (SodA2) Superoxide dismutase SodA 1.53 697
SA1836 GroEL Chaperonin GroEL 0.37 267
SA1898 Hypothetical protein, similar to SceD precursor 0.27 552
SA1905 AtpD F0F1 ATP synthase subunit beta 0.28 383
SA1915 GlyA Serine hydroxymethyltransferase 1.24 364
SA1915 GlyA Serine hydroxymethyltransferase 0.90 367
SA1927 FbaA Fructose-bisphosphate aldolase 0.61 530
SA1959 GlmS Glucosamine-fructose-6-phosphate transferase 1.12 218
SA1984 Asp23 Alkaline shock protein 23 1.66 827
SA2003 HysA Hyaluronate lyase precursor 0.30 156
SA2093 SsaA Secretory antigen precursor SsaA homologue 0.09 592
SA2093 SsaA Secretory antigen precursor SsaA homologue 0.10 593
SA2097 Hypothetical protein, similar to secretory antigen precursor SsaA 0.24 860
SA2204 GpmA Phosphoglycerate mutase, pgm homologue 3.01 583
SA2204 GpmA Phosphoglycerate mutase, pgm homologue 1.36 585
SA2206 Sbi IgG-binding protein SBI 0.29 387
SA2208 HlgC Gamma-haemolysin component C 3.73 535
SA2209 HlgB Gamma-haemolysin component B 2.47 497
SA2334 MmvaS 3-Hydroxy-3-methylglutaryl CoA synthase 0.68 434
SA2336 ClpL ATP-dependent Clp proteinase chain clpL 0.35 210
SA2356 IsaA Immunodominant antigen A 0.23 616
SA2356 IsaA Immunodominant antigen A 0.22 635
SA2356 IsaA Immunodominant antigen A 2.08 747
SA2356 IsaA Immunodominant antigen A 1.43 822
SA2356 IsaA Immunodominant antigen A 0.24 908
SA2430 Aur Zinc metalloproteinase aureolysin 0.21 471
SA2430 Aur Zinc metalloproteinase aureolysin 0.79 496
SA2437 Hypothetical protein, similar to autolysin precursor 0.36 191
SA2437 Hypothetical protein, similar to autolysin precursor 0.19 193
SA2437 Hypothetical protein, similar to autolysin precursor 0.16 195
SA2437 Hypothetical protein, similar to autolysin precursor 0.11 200
SA2437 Hypothetical protein, similar to autolysin precursor 0.88 223
SA2437 Hypothetical protein, similar to autolysin precursor 1.11 235
SA2437 Hypothetical protein, similar to autolysin precursor 1.15 236
SA2437 Hypothetical protein, similar to autolysin precursor 0.10 245
SA2437 Hypothetical protein, similar to autolysin precursor 0.78 269
SA2437 Hypothetical protein, similar to autolysin precursor 0.41 422
Table of all identified protein spots from the extracellular fraction. Data for proteins with a spot vol. ratio of ≥2 and ≤0.5 are shown. All proteins 
had a significance level of 0.05 or less (T test 5 % cut-off). Proteins highlighted in italics are significantly changed in the two phases of growth
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should be undertaken to verify changes in expression using 
these types of technologies.
Effect of C-6-H on the S. aureus regulatory system saeRS
The SaeRS response regulator is a key system that controls 
the expression of virulence determinants in S. aureus and 
is required for pathogenesis (Giraudo et al. 1994, 1997; 
Goerke et al. 2001, 2005; Harraghy et al. 2005). Interest-
ingly, saeRS was down-regulated in response to C-6-H as 
shown by the transcriptome data. Further, many members 
of its regulon were decreased in expression as well, which 
suggests that signal transduction by SaeS may be altered 
as a direct, or indirect, consequence of C-6-H. It has been 
proposed earlier that fatty acids (such as GML or lauric 
acid) might affect the cell membrane and therefore disrupt 
important signalling mechanisms (Schlievert et al. 1992; 
Holland et al. 1994; Projan et al. 1994; Ruzin and Novick 
1998; Vetter and Schlievert 2005). To investigate the role of 
the SaeRS system in the molecular mechanism of C-6-H, 
qRT-PCR experiments were performed. The transcription 
of hla in the presence of a sub-MIC of C-6-H using the saeS 
(saeS∷Tn551) and saeR (saeR∷Tn551) mutant strains in 
the SH1000 background was measured. In SH1000 wt, the 
expression of hla showed a reduction of over fourfold and 
20-fold in the presence of C-6-H for 10 and 60 min, respec-
tively. The saeS mutant strain (saeS∷Tn551) revealed no 
significant change in hla expression in the presence of C-6-
H, at 10 or 60 min (Fig. 4). Similar results were observed 
using the saeR mutant strain (saeR∷Tn551) which also 
Fig. 5  2D gel image false-colour dual-channel of extracellular pro-
teins in exponential phase with and without C-6-H. Merged 2D gel 
images of S. aureus SH1000 extracellular proteins from exponential 
phase treated with or without 10 µg/ml C-6-H. Control gel shown in 
green, treated samples shown in red and equal expression shown in 
yellow. Spots were identified via MALDI-TOF
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showed no significant difference in hla expression in the 
presence of C-6-H, suggesting that the two-component 
system saeRS is implicated in the molecular mechanism of 
C-6-H. The molecular mechanism of C-6-H in virulence 
determinant inhibition has not as yet been revealed, but an 
interference of the signal transduction system in S. aureus 
is a possible scenario.
Effect of C-6-H on protein profiles
Transcriptome analysis revealed a pleiotropic effect of 
C-6-H on gene expression but whether this is translated 
into significant changes in protein levels and thus activities 
required a proteomic analysis. The effect of a sub-inhibi-
tory concentration of C-6-H on the extracellular proteins of 
S. aureus SH1000 was determined using the 2D gel tech-
nique (Table 4).
For the 2D gel analysis of extracellular proteins, cul-
ture supernatant was treated with 10 % (w/v) fresh TCA to 
precipitate all extracellular proteins. Figures 5 and 6 show 
the extracellular protein expression of S. aureus in early 
exponential phase (OD600 1.0) and stationary phase (16 h 
incubation). In total, 103 different proteins were identified 
in the extracellular protein fraction. Nine proteins showed 
an increase in the amount in stationary phase and 13 pro-
teins showed a decrease in level compared with exponential 
phase (Table 5). As expected, virulence determinants that 
are involved in host defence evasion as well as invasion and 
tissue penetration showed an increased level in stationary 
phase. For example, α-haemolysin (Hla) was over 4.5-fold 
Fig. 6  2D gel image false-colour dual-channel of extracellular pro-
teins in stationary phase with and without C-6-H. Merged 2D gel 
images of S. aureus SH1000 extracellular proteins from stationary 
phase treated with or without 10 µg/ml C-6-H. Control gel shown in 
green, treated samples shown in red and equal expression shown in 
yellow. Spots were identified via MALDI-TOF
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increased in level in stationary phase. Also, the glycerol 
ester hydrolase (Geh) main spots were increased ninefold 
to 21-fold (Table 4). Decreased protein levels in stationary 
phase were shown by several hypothetical proteins as well 
as the peptidoglycan hydrolase (LytM), immunodominant 
antigen A (IsaA) and secretory antigen (SsaA).
In early exponential phase (OD600 1.0), the levels of 
15 proteins were altered (≥twofold) in the presence of 
C-6-H (Table 6). Thirteen proteins showed a reduced level 
and 2 proteins showed an increased level in the presence 
of C-6-H. In stationary phase (16 h), 18 proteins showed 
an altered level of expression in the presence of C-6-H. 
Thirteen proteins were reduced and 5 were increased in 
level (Table 6). In the presence of C-6-H, several virulence 
determinants were reduced in level in exponential phase. 
The β-haemolysin (Hlb) and γ-haemolysin (HlgC) showed 
fivefold and 2.5-fold reduction in exponential phase. At 
stationary phase, Hlb showed no alteration due to C-6-H, 
but HlgC and HlgB were 3.5-fold reduced. The addition 
of C-6-H surprisingly showed no apparent effect on Hla 
level at either growth phase. The lipase (Geh) showed 
a growth phase-dependent response to C-6-H as it was 
reduced in exponential phase but induced in stationary 
phase (Table 5).
One hundred and sixty-six cytoplasmic soluble pro-
teins were identified in total and analysed by MALDI-TOF 
mass spectrometry. The differences in protein expression 
of exponential and stationary phase cell growth are shown 
in Table 7, and the effects of C-6-H are shown in Table 8 
and Figs. 7, 8. The cytoplasmic proteins of S. aureus in 
early exponential phase (OD600 1.0) and stationary phase 
(16 h incubation) were compared. Twenty proteins show 
Table 5  Growth phase-dependent changes in extracellular protein profile
Comparison of the pattern of extracellular protein expression in exponential phase (OD600 1.0) and stationary phase of S. aureus. Data for pro-
teins with a spot vol. ratio of ≥2 and ≤0.5 are shown. All genes had a significance level of 0.05 or less (T test 5 % cut-off)
ORF N315 Protein Gene product OD 1.0 versus 16 h Spot ID
SA0265 LytM Peptidoglycan hydrolase 0.15 454
SA0265 LytM Peptidoglycan hydrolase 0.13 460
SA0309 Geh Glycerol ester hydrolase 3.08 171
SA0309 Geh Glycerol ester hydrolase 9.64 199
SA0309 Geh Glycerol ester hydrolase 21.07 229
SA0309 Geh Glycerol ester hydrolase 8.89 424
SA0375 GuaB Inositol-monophosphate dehydrogenase 0.34 308
SA0393 Set15 Superantigen-like protein 0.12 676
SA0505 FusA Elongation factor G 0.14 162
SA0544 Putative haem peroxidase 0.21 618
SA0935 PtsI Phosphoenolpyruvate-protein phosphatase 0.09 244
SA0945 PdhC Branched-chain alpha-keto acid dehydrogenase subunit E2 0.47 192
SA1007 Hla Alpha-haemolysin 5.28 531
SA1007 Hla Alpha-haemolysin 4.60 541
SA1177 Tkt Transketolase 0.40 197
SA1499 Tig Trigger factor 0.10 231
SA1627 SplF Serine protease SplE, putative 7.88 670
SA1628 SplD Serine protease SplD 4.68 666
SA1630 SplB Serine protease SplB 6.64 646
SA1725 Staphopain, cysteine proteinase 6.01 754
SA1898 Hypothetical protein, similar to SceD precursor 0.27 552
SA2093 SsaA Secretory antigen precursor SsaA homologue 0.09 592
SA2093 SsaA Secretory antigen precursor SsaA homologue 0.10 593
SA2204 GpmA Phosphoglycerate mutase, pgm homologue 3.01 583
SA2208 HlgC Gamma-haemolysin component C 3.73 535
SA2209 HlgB Gamma-haemolysin component B 2.47 497
SA2356 IsaA Immunodominant antigen A 0.22 635
SA2437 Hypothetical protein, similar to autolysin precursor 0.16 195
SA2437 Hypothetical protein, similar to autolysin precursor 0.41 422
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Table 6  Effect of C-6-H on extracellular protein profile
Comparison of extracellular protein production in exponential phase (OD600 1.0) and stationary phase in the presence of sub-MIC C-6-H. Data 
for proteins with a spot vol. ratio of ≥2 and ≤0.5 are shown. All proteins had a significance level of 0.05 or less (T test 5 % cut-off)
ORF N315 Protein Gene product Expression C6H
OD 1.0 16 h Spot ID (OD 1.0) Spot ID (16 h)
SA0131 Pnp (deoD1) Purine nucleoside phosphorylase – 0.33 654
SA0265 LytM Peptidoglycan hydrolase 2.08 – 454
SA0309 Geh Glycerol ester hydrolase 0.23 – 421
SA0309 Geh Glycerol ester hydrolase – 7.38 212
SA0366 AhpC Alkyl hydroperoxide reductase subunit C – 0.18 712
SA0505 FusA Elongation factor G 0.20 – 162
SA0506 Tuf Elongation factor Tu 0.17 – 371
SA0820 GlpQ Glycerophosphoryl diester phosphodiesterase – 2.88 569
SA0843 Fab (fabF) 3-Oxoacyl-synthase 0.10 – 362
SA0900 SspB1 Cysteine protease precursor SspB – 7.57 427
SA0900 SspB1 Cysteine protease precursor SspB – 5.78 432
SA0901 SspA V8 protease – 13.24 478
SA0901 SspA V8 protease – 9.44 483
SA0901 SspA V8 protease – 5.19 490
SA0935 PtsI Phosphoenolpyruvate-protein phosphatase 0.18 – 244
SA1100 Tsf Elongation factor Ts 0.47 – 470
SA1177 Tkt Transketolase 0.25 – 201
SA1184 CitB (acnA) Aconitate hydratase 0.13 – 128
SA1409 Dnak Molecular chaperone DnaK 0.19 – 226
SA1627 SplF Serine protease SplE, putative – 0.36 670
SA1630 SplB Serine protease SplB – 0.29 646
SA1631 SplA Serine protease SplA – 0.27 642
SA1631 SplA Serine protease SplA – 0.13 647
SA1637 LukD Leukotoxin, LukD – 0.17 487
SA1671 Hypothetical protein – 0.17 698
SA1725 SspB2 Staphopain, cysteine proteinase – 0.19 754
SA1811 Hlb Beta-hemolsysin 0.17 – 505
SA1811 Hlb Beta-hemolsysin 0.19 – 509
SA1811 Hlb Beta-hemolsysin 0.16 – 519
SA1812 Hypothetical protein – 0.44 500
SA1813 Hypothetical protein – 0.07 494
SA1959 GlmS Glucosamine-fructose-6-phosphate transferase 0.05 – 218
SA2093 SsaA Secretory antigen precursor SsaA homologue 4.74 – 592
SA2093 SsaA Secretory antigen precursor SsaA homologue 6.24 – 593
SA2204 GpmA Phosphoglycerate mutase, pgm homologue 0.08 – 585
SA2208 HlgC Gamma-haemolysin component C 0.38 – 535
SA2208 HlgC Gamma-haemolysin component C – 0.33 535
SA2209 HlgB Gamma-haemolysin component B – 0.22 497
SA2356 IsaA Immunodominant antigen A – 0.28 616
SA2356 IsaA Immunodominant antigen A – 0.21 635
SA2356 IsaA Immunodominant antigen A – 0.16 747
SA2437 Hypothetical protein, similar to autolysin – 0.43 223
SA2437 Hypothetical protein, similar to autolysin – 2.38 236
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Table 7  Growth phase-dependent changes in cytoplasmic protein profile
ORF N315 Protein Gene product OD 1.0 versus 16 h
SA0149 CapF Capsular polysaccharide synthesis enzyme Cap5F 2.18
SA0218 MB Formate acetyltransferase 3.20
SA0224 Hypothetical protein, similar to 3-hydroxyacyl-CoA dehydrogenase 28.28
SA0372 Hypothetical protein 4.24
SA0506 Tuf Elongation factor Tu 0.28
SA0506 Tuf Elongation factor Tu 0.10
SA0513 Hypothetical protein 0.35
SA0564 ArgS Arginyl-tRNA synthetase 0.50
SA0707 Hypothetical protein 3.06
SA0730 Pgm Phosphoglyceromutase 0.30
SA0755 Organic hydroperoxide resistance protein-like 2.34
SA0774 Hypothetical protein 0.34
SA0793 DltA d-alanine-poly(phosphoribitol) ligase subunit 1 0.40
SA0842 FabH FabH, 3-oxoacyl-(acyl carrier protein) synthase homologue 0.40
SA0843 Fab 3-oxoacyl-synthase 0.44
SA0869 FabI Enoyl-(acyl carrier protein) reductase 0.35
SA0959 GTP-binding elongation factor homologue 0.32
SA1019 Hypothetical protein 2.19
SA1045 PyrAA Carbamoyl phosphate synthase small subunit 0.39
SA1073 FabD Malonyl CoA-acyl carrier protein transacylase 0.48
SA1096 ClpQ ATP-dependent protease peptidase subunit 2.46
SA1115 RibC Riboflavin kinase/FAD synthase ribC 0.17
SA1224 ABC transporter (ATP-binding protein) homologue 0.30
SA1224 ABC transporter (ATP-binding protein) homologue 0.36
SA1307 EngA GTP-binding protein engA 0.34
SA1309 Cmk Cytidylate kinase 0.36
SA1343 Hypothetical protein, similar to tripeptidase 7.03
SA1410 GrpE Heat shock protein GrpE 0.46
SA1456 AspS Aspartyl-tRNA synthetase 0.49
SA1456 AspS Aspartyl-tRNA synthetase 0.41
SA1522 AccA Acetyl-CoA carboxylase carboxyltransferase subunit alpha 0.45
SA1553 Fhs Formate-tetrahydrofolate ligase 2.77
SA1553 Fhs Formate-tetrahydrofolate ligase 2.13
SA1609 PckA Phosphoenolpyruvate carboxykinase 6.03
SA1609 PckA Phosphoenolpyruvate carboxykinase 3.67
SA1609 PckA Phosphoenolpyruvate carboxykinase 6.65
SA1692 Hypothetical protein 2.37
SA1709 Ferritin 4.20
SA1724 PurB Adenylosuccinate lyase 2.12
SA1840 Hypothetical protein 2.02
SA1929 PyrG CTP synthase 0.43
SA1936 LuxS S-ribosylhomocysteinase 0.39
SA1984 Asp23 Alkaline shock protein 23 13.54
SA1984 Asp23 Alkaline shock protein 23 10.13
SA1984 Asp23 Alkaline shock protein 23 8.04
SA2098 Putative 2-hydroxyacid dehydrogenase SA2098 2.25
SA2125 Formimidoylglutamase 2.12
SA2240 Hypothetical protein, similar to para-nitrobenzyl esterase chain A 8.60
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an increase and 22 a decrease in level in stationary phase 
(Table 7), with a variety of predicted roles.
In early exponential phase, the expression levels of 17 
proteins were altered (≥2-fold) in the presence of C-6-H 
(Table 8). Eleven proteins showed a decrease and 6 an 
increase in level due to C-6-H. In stationary phase, 9 pro-
teins were increased and 2 reduced in the presence of 
C-6-H. The greatest induction by C-6-H was seen for UreC 
in exponential phase (14-fold). Also, UreE showed a five-
fold induction in protein level (Table 8). The increased ure-
ase level is in accordance with the array data (Table S1). 
A variety of other metabolic proteins were also affected by 
C-6-H, which alludes to a generalised effect of the inhibitor 
on cellular processes.
Comparison of the pattern of cytoplasmic protein expression in exponential phase (OD600 1.0) and stationary phase of S. aureus. Proteins with a 
spot vol. ratio of ≥2 and ≤0.5 are shown. All proteins had a significant level of 0.05 or less (T test 5 % cut-off)
Table 7  continued
ORF N315 Protein Gene product OD 1.0 versus 16 h
SA2317 Hypothetical protein 0.44
SA2336 ClpL ATP-dependent Clp proteinase chain clpL 2.57
Table 8  Effect of C-6-H on 
cytoplasmic protein profile
Comparison of cytoplasmic 
protein expression in 
exponential phase (OD600 1.0) 
and stationary phase in the 
presence of sub-MIC C-6-H. 
Data for proteins with a spot 
vol. ratio of ≥2 and ≤0.5 are 
shown. All proteins had a 
significance level of 0.05 or less 
(T test 5 % cut-off)
ORF N315 Protein Gene product Expression C6H
OD600 1.0 16 h
SA0165 Hypothetical protein, similar to alpha-helical coiled-coil – 0.15
SA0367 NADPH-dependent oxidoreductase – 2.13
SA0419 MetB Cystathionine gamma-synthase 2.11 –
SA0506 Tuf Elongation factor Tu 2.31 –
SA0506 Tuf Elongation factor Tu – 2.46
SA0513 Hypothetical protein 0.48 –
SA0707 Hypothetical protein 0.44 –
SA0758 Hypothetical protein, similar to thioredoxin 0.50 –
SA0869 FabI Enoyl-(acyl carrier protein) reductase 0.40 –
SA0884 Lipoate-protein ligase homologue – 2.09
SA1045 PyrAA Carbamoyl phosphate synthase small subunit 0.35 –
SA1112 InfB Translation initiation factor IF-2 – 3.52
SA1115 RibC Riboflavin kinase/FAD synthase ribC 0.21 –
SA1258 Hypothetical protein 0.10 –
SA1522 AccA Acetyl-CoA carboxylase carboxyltransferase subunit alpha 0.35 –
SA1868 Hypothetical protein 0.23 –
SA1943 Hypothetical protein 0.19 –
SA1959 GlmS Glucosamine-fructose-6-phosphate aminotransferase – 2.15
SA1959 GlmS Glucosamine-fructose-6-phosphate aminotransferase – 2.95
SA1959 GlmS Glucosamine-fructose-6-phosphate aminotransferase 2.15 –
SA1984 Asp23 Alkaline shock protein 23 – 0.37
SA2084 UreC Urease subunit alpha 14.42 –
SA2085 UreE Urease accessory protein UreE 5.85 –
SA2085 UreE Urease accessory protein UreE – 3.28
SA2098 Putative 2-hydroxyacid dehydrogenase SA2098 – 2.09
SA2311 Putative NAD(P)H nitroreductase SA2311 – 2.62
SA2312 Ddh d-lactate dehydrogenase 2.44 –
SA2336 ClpL ATP-dependent Clp proteinase chain clpL – 2.26
SA2336 ClpL ATP-dependent Clp proteinase chain clpL – 2.62
SA2400 Mqo2 Malate: quinone oxidoreductase 0.44 –
SA2400 Mqo2 Malate: quinone oxidoreductase 0.27 –
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Conclusions
There was broad (but not exact) correlation between the 
effects of C-6-H on gene expression and protein level 
revealing a pleiotropic alteration in cellular physiology and 
virulence. Despite multiple changes in gene expression as a 
result of C-6-H exposure, no single resistance mechanism 
could be identified, which might suggest the contribution 
of several factors. Our data, however, support the hypoth-
esis that the key regulator of virulence determinant produc-
tion, SaeR, is affected by C-6-H and results in the reduced 
expression of several toxins. This would make sense as skin 
fatty acids are key markers for an environment in which 
S. aureus will colonise as part of the commensal flora. 
Expression of components able to disrupt the host will 
destroy this niche and potentiate other defences, thus plac-
ing the organism at risk.
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